Pages that link to "Q36804819"
Jump to navigation
Jump to search
The following pages link to n-3 PUFA in CVD: influence of cytokine polymorphism (Q36804819):
Displaying 14 items.
- Omega-3 supplementation on inflammatory markers in patients with chronic Chagas cardiomyopathy: a randomized clinical study. (Q33785166) (← links)
- Dietary supplementation with fish gelatine modifies nutrient intake and leads to sex-dependent responses in TAG and C-reactive protein levels of insulin-resistant subjects (Q34127263) (← links)
- n-3 Fatty acids and cardiovascular disease: actions and molecular mechanisms (Q36661439) (← links)
- New approaches to therapy with omega-3 fatty acids (Q37119269) (← links)
- A select review reporting the quality of studies measuring endothelial dysfunction in randomised diet intervention trials (Q38265443) (← links)
- Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists? (Q40111866) (← links)
- Eicosapentaenoic acid reduces warfarin-induced arterial calcification in rats (Q42769596) (← links)
- Use of red blood cell fatty-acid profiles as biomarkers in cardiac disease (Q43061596) (← links)
- Ω3 Supplementation and intermittent hypobaric hypoxia induce cardioprotection enhancing antioxidant mechanisms in adult rats. (Q43167524) (← links)
- Gene-PUFA interactions and obesity risk (Q43778070) (← links)
- Effects of n-3 fatty acids and acute exercise on endothelium-dependent vasorelaxation in healthy rat aorta. (Q46381410) (← links)
- Plasma n-3 Polyunsaturated Fatty Acids are negatively associated with obesity (Q51424936) (← links)
- A new insight to bone turnover: role of ω-3 polyunsaturated fatty acids. (Q54494440) (← links)
- Effects of similar intakes of marine n-3 fatty acids from enriched food products and fish oil on cardiovascular risk markers in healthy human subjects (Q84943203) (← links)